complement inactivating agents

Preferred Label : complement inactivating agents;

MeSH definition : Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host.;

MeSH synonym : agents, complement inactivating; inactivating agents, complement; complement inhibiting agents; agents, complement inhibiting; inhibiting agents, complement; Complement Inhibitors; Inhibitors, Complement; Complement Inhibitor; Inhibitor, Complement;

MeSH hyponym : complement cytolysis inhibiting agents;

MeSH annotation : do not confuse with COMPLEMENT INACTIVATOR PROTEINS;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D051056;

UMLS CUI

C1564892;

ATC code(s)
- Complement inhibitors [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Complement inhibitors [ATC Code]
Currated CISMeF NLP mapping
- Complement Inhibitor [NCIt concept]
- Substance with complement inhibitor mechanism of action (substance) [SNOMED CT concept]
- complement inhibitor, nos [SNOMED Notion]
Indexing information
- (2R,3R,4R)-3',5'-dimethoxy-3,4,7,4'-tetrahydroxy-flavan [MeSH Supplementary Concept]
- 2-(4-hydroxy-3-methoxybenzoyl)-4-methoxy-benzaldehyde [MeSH Supplementary Concept]
- soluble complement inhibitor 1 [MeSH Supplementary Concept]
Record concept(s)
- complement cytolysis inhibiting agents [MeSH concept]
- complement inactivating agents [MeSH concept]
See also inter- (CISMeF)
- Complement inhibitor (disposition) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
Substance(s)
- C5a peptidase [MeSH Supplementary Concept]
- CD59 Antigens [MeSH Descriptor]
- K 76 carboxylic acid [MeSH Supplementary Concept]
- cobra venom factor [MeSH Supplementary Concept]
- complement C1 inhibitor protein [MeSH Descriptor]
- complement C3 nephritic factor [MeSH Descriptor]
- complement C3b inactivator proteins [MeSH Descriptor]
- complement c1 inactivator proteins [MeSH Descriptor]
- complement c4b-binding protein [MeSH Descriptor]
- complement factor I [MeSH Descriptor]
- complement factor h [MeSH Descriptor]
- complement inactivator proteins [MeSH Descriptor]
- eculizumab [MeSH Supplementary Concept]
- nafamostat [MeSH Supplementary Concept]
- ravulizumab [MeSH Supplementary Concept]
- vilobelimab [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Complement Inhibitor [NCIt concept]
- Complement inhibitors [ATC Code]
- Substance with complement inhibitor mechanism of action (substance) [SNOMED CT concept]
- complement inhibitor, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients